Skip to main content
67°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acurx Pharmaceuticals, Inc. - Common Stock
(NQ:
ACXP
)
0.3200
-0.0100 (-3.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acurx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
A Preview Of Acurx Pharmaceuticals's Earnings
March 15, 2024
Via
Benzinga
New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV
February 29, 2024
Via
AB Newswire
Acurx Pharmaceuticals’ Phase 2b Results For Ibezapolstat Bests Standard Of Care Vancomycin To Treat C. Difficile ($ACXP)
January 22, 2024
Via
AB Newswire
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 17, 2024
Via
Benzinga
Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?
January 17, 2024
Acurx Pharmaceuticals' ibezapolstat outperforms vancomycin with a 94% eradication rate. Stay tuned for Q1 2024 updates on Extended Clinical Cure and microbiome data.
Via
Benzinga
Acurx Pharmaceuticals: Q3 Earnings Insights
November 14, 2023
Via
Benzinga
What's Going On With Acurx Pharmaceuticals Stock?
October 09, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares surged Monday.
Via
Benzinga
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Leading the Way in Monday Trading Based on Percentage Gain
October 09, 2023
Via
Investor Brand Network
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 17, 2024
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 14, 2023
Via
Benzinga
Acurx's Antibiotic Shows All Patients With Clinical Cure Remained Infection-Free After End Of Treatment
December 11, 2023
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) released Phase 2b results showing 100% of C.
Via
Benzinga
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge...
Via
Benzinga
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
November 06, 2023
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
Acurx Pharmaceuticals Stock Is Plummeting After Biotech Publishes Phase 2 Results
November 02, 2023
Acurx Pharmaceuticals Inc (NASDAQ: ACXP) shares are trading lower after the company
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 27, 2023
Via
Benzinga
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
October 27, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Thursday's Intraday Session
October 19, 2023
Via
Benzinga
What's Going On With Acurx Pharmaceuticals Inc Stock Today?
October 18, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares are trading higher Wednesday, though the stock remains down more than 30% over the last month.
Via
Benzinga
Top 3 Health Care Stocks That May Implode This Quarter
October 16, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 12, 2023
Gainers
Via
Benzinga
What's Going On With Acurx Pharmaceuticals Stock Now?
October 12, 2023
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) shares are blasting higher Thursday and have gained more than 300% over the last five days.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 03, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.